Table of contents

  • Preliminary material 
    • Title page and verso
    • Contents
    • List of tables
    • List of figures
    • List of boxes
    • Acknowledgments
    • Abbreviations
    • Highlights
      • Treatment agencies
      • Client profile
      • Principal drug of concern
      • Treatment programs
      • Special theme - clients aged 10 - 29 years
      • Data quality
  • Sections
    1. Introduction
      1. Background
      2. The AODTS - NMDS collection
      3. The 2002 - 03 AODTS - NMDS collection
      4. Recent drug use
    2. Treatment agency profile
      1. Establishment sector
      2. Location of treatment agencies
    3. Client profile
      1. Closed treatment episodes and client registrations
      2. Client type and jurisdictions
      3. Sex and age
      4. Indigenous status
      5. Country of birth and preferred language
    4. Drugs of concern
      1. Jurisdictions and principal drug of concern
      2. Sex, age and principal drug of concern
      3. Country of birth and principal drug of concern
      4. Indigenous status and principal drug of concern
      5. Geographic location and principal drug of concern
      6. Source of referral and principal drug of concern
      7. Other drugs of concern
      8. Injecting drug use and method of use
      9. Reason for cessation and principal drug of concern
    5. Treatment programs 
      1. Jurisdictions and treatment programs
      2. Main treatment for selected principal drugs
      3. Client type, source of referral and treatment programs
      4. Sex, age and treatment program
      5. Indigenous status and treatment program
      6. Geographic location and treatment program
      7. Additional treatments
      8. Reason for cessation and treatment program
      9. Treatment delivery setting and treatment program
    6. Special theme - clients aged 10 - 29 years
      1. Client profile
      2. Drugs of concern
      3. Treatment programs
    7. Other data collections
      1. Background
      2. Monitoring alcohol and other drug problems
      3. Use, mortality and morbidity data
      4. National pharmacotherapy statistics
    8. Data quality of the AODTS - NMDS in 2002 - 03
      1. Introduction
      2. Data quality
  • End matter
    • 9 Appendixes
      • Appendix 1: Data elements included in the AODTS - NMDS for 2002 - 03
      • Appendix 2: Technical notes
      • Appendix 3: AODTS - NMDS treatment types
      • Appendix 4: Detailed tables
      • Appendix 5: Australian Standard Geographical Classification
      • Appendix 6: Australian Standard Classification of Drugs of Concern (ASCDC)
    • 10 References